Original article
Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients
Salwa Bakra,
, Karem Mohamed Salemb, Ahmed Mohammed Rashedb, Mohamed E A Tantawyc, Asmaa Younis Elsaryd, Hanan Abdelmoneam Shamardle, Eman Mahmoud Ezzatb
a Clinical Pathology/ Hematology, Faculty of Medicine, Fayoum University, Fayoum, Egypt
b Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt
c Faculty of Medicine, Menoufia University, Egypt
d Public Health and Community Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt
e Medical Pharmacology, Faculty of Medicine, Fayoum University, Fayoum, Egypt
Lido
1658
Vezesque se leu este artigo
376
Total PDF
1282
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 10 | 92 | 13 | 105 |
| 2025 9 | 137 | 46 | 183 |
| 2025 8 | 193 | 23 | 216 |
| 2025 7 | 129 | 34 | 163 |
| 2025 6 | 59 | 23 | 82 |
| 2025 5 | 76 | 30 | 106 |
| 2025 4 | 59 | 17 | 76 |
| 2025 3 | 80 | 18 | 98 |
| 2025 2 | 54 | 18 | 72 |
| 2025 1 | 53 | 32 | 85 |
| 2024 12 | 60 | 21 | 81 |
| 2024 11 | 75 | 15 | 90 |
| 2024 10 | 62 | 29 | 91 |
| 2024 9 | 99 | 23 | 122 |
| 2024 8 | 54 | 34 | 88 |
Mostrar tudo
